511 results about "Poloxamer" patented technology

The invention provides a nitrification inhibitor and a preparation method thereof as well as stable urea and a preparation method thereof, and relates to the technical field of fertilizers. The nitrification inhibitor provided by the invention is prepared from the following components in percentage by mass: 20 to 45 percent of 3, 4-dimethyl pyrazole phosphate (DMPP), 30 to 70 percent of amino acid and the balance of auxiliaries, the auxiliary agent is one or more of polysaccharide, polyvinylpyrrolidone, poloxamer and carbomer. According to the invention, the DMPP and the amino acid are compounded, the amino acid is used as a stabilizer of the DMPP, so that the stability of the DMPP can be remarkably improved, and meanwhile, the polymer additive is used as an adhesive, so that the stability of the DMPP can be further improved. The nitrification inhibitor provided by the invention has excellent stability; the stable urea can be obtained by adopting an endogenous adding mode and adding the stable urea into the urea with relatively low loss, and the stable urea has multiple effects of improving the urea utilization rate, improving the crop quality, improving the soil biological environment, improving the soil fertility and the like.

The invention provides a neurosteroid derivative solid dispersion, a preparation method and application thereof, and a medicine containing a hot-melt extrusion solid dispersion, and belongs to the technical field of pharmacy. The preparation method comprises the following steps: carrying out melt extrusion on a raw material mixture at 125-160 DEG C to obtain the neurosteroid derivative solid dispersion, the mixed material comprises an active component, a plasticizer and a carrier material in a mass ratio of 10: (1-15): (10-90); the active component comprises at least one of a neurosteroid derivative (with a structure as shown in a formula 1), an isomer, a solvate and a pharmaceutically acceptable salt thereof; the plasticizer is selected from one or more of polyethylene glycol, poloxamer and Tween, and the average molecular weight of the polyethylene glycol is 1t; 6000, 6000; active components in the neurosteroid derivative solid dispersion exist in an amorphous state. The neurosteroid derivative in the neurosteroid derivative solid dispersion disclosed by the invention has relatively high oral bioavailability. # imgabs0 #

The invention discloses a pharmaceutical composition, a preparation containing the pharmaceutical composition, a kit containing the pharmaceutical composition, and a preparation method and application of the pharmaceutical composition. The pharmaceutical composition comprises an active pharmaceutical ingredient and a hot melt adhesive, wherein the active pharmaceutical ingredient is voriconazole, and the hot-melt adhesive is selected from an A-type hot-melt adhesive, namely poloxamer P188 and / or poloxamer P407, and a B-type hot-melt adhesive, namely poloxamer P188 and / or poloxamer P407; or the B-type hot melt adhesive is polyethylene glycol 6000; the mass percent of the B-type hot melt adhesive in the pharmaceutical composition is 12%-25%; the pharmaceutical composition is a pharmaceutical composition in the form of hot-melt granulated particles. According to the pharmaceutical composition and the preparation and the kit containing the pharmaceutical composition, the stability of active pharmaceutical ingredients can be improved, swallowing of a patient can be further improved, and the medicine taking compliance of the patient during actual taking can be improved.

The invention relates to the technical field of oral membranes, in particular to a multilayer oral membrane and a preparation method thereof. The invention provides an oral membrane composition, which comprises semeglutide and pharmaceutically acceptable auxiliary materials, and is characterized in that the composition is formed by combining a drug-containing biological adhesion layer and a backing layer, and the backing layer mainly comprises a membrane forming material, a solvent and a plasticizer; the drug-containing biological adhesion layer mainly comprises semeglutide, a film-forming material, an adhesive, a pH regulator, a flavoring agent and a solvent. By preparing the double-layer oral membrane, the semeglutide is administrated through the oral cavity, and after the insoluble or slowly eroded / dissolved backing layer (preventing saliva from dissolving the medicine) and the adhesive layer containing the main medicine are combined together, the one-way delivery of the main medicine can be realized; through experiments, it is accidentally found that when temperature-sensitive materials such as poloxamer are added to be combined with a conventional adhesive for use, the residence time of the medicine in the oral mucosa can be remarkably prolonged, the curative effect of the medicine is improved, and the main mechanism is that after the medicine is administered, in the oral temperature environment, after the medicine makes contact with mucus on the surface of the oral mucosa, the oral mucosa does not adhere to the oral mucosa. And after the entanglement and piling effects among poloxamer micelles are intensified to form gel, the gel and a conventional adhesive are cooperated to improve the adhesion between the oral membrane and the oral mucosa. Besides, the medicine can be removed at any time, blood sugar can be better controlled, T2DM complications can be better reduced, a more ideal taking mode is provided for weight loss patients, and a new administration mode is provided for reducing blood sugar and reducing weight. The prepared oral cavity membrane is small in size, light in weight, thin, convenient to apply, carry and transport, safe and environmentally friendly to use and capable of meeting the requirements of old people and travelers.

The invention discloses an adapalene external preparation and a preparation method thereof, and relates to the technical field of adapalene preparation preparation. The adapalene gel comprises the following raw materials in percentage by mass: 4.5-7.5% of adapalene, 3.5-8% of a gel base material, 2-4.5% of cellulose, 0.5-2% of a penetration enhancer, 18-25% of a water-retaining agent, 2-5% of a surfactant, a pH value regulator and the balance of water, the dosage of the pH value regulator is based on the standard that the pH value of the adapalene external preparation is regulated to 7-7.5; the gel base material comprises poloxamer or carbomer, and further comprises sa-hao seed gum, and the use amount of the sa-hao seed gum accounts for 25-35% of the total mass of the gel base material. According to the adapalene external preparation provided by the invention, the irritation of adapalene to the skin is basically eliminated by utilizing the effects of the gel base material consisting of poloxamer or carbomer and sa-hao seed gum and the surfactant; the adhesive has good cohesiveness and water-retaining property, can keep the affected part moist after being smeared, promotes medicine absorption, and avoids being wiped off or automatically falling off; the stability is improved, and the medicine slow release time is indirectly prolonged.

The invention discloses a long-acting analgesic compound as well as a preparation method and application thereof. The preparation method comprises the following steps: preparing a mixed solution containing a polymer, a local anesthetic, a non-steroidal anti-inflammatory drug and a solvent into drug-loaded microspheres through an electrostatic spraying technology; the preparation method comprises the following steps: dissolving poloxamer and a natural polymer material in water to obtain a hydrogel solution; and uniformly mixing the drug-loaded microspheres and a hydrogel solution to prepare the long-acting analgesic compound. The long-acting analgesic compound comprises drug-loaded microspheres and hydrogel, the long-acting analgesic compound and the hydrogel are both of a three-dimensional porous network structure, the drug-loaded microspheres are evenly dispersed in the hydrogel, and the drug-loaded microspheres are of a solid spherical structure. The advantages of electrostatic spraying microspheres and hydrogel are combined, the preparation method is mild in condition and simple in process, and the preparation process is non-toxic and harmless; the long-acting analgesic compound has the advantages of thermosensitivity, injectability, high drug loading rate and the like, and can be effectively applied to preparation of analgesic products.

The invention discloses a quick and long-acting gynecological antibacterial gel and a preparation method thereof. According to the formula of the gynecological antibacterial gel, a plurality of key components are selected and combined, and the gynecological antibacterial gel specifically comprises the following components in parts by weight: 5-15 parts of poloxamer, 0.5-1 part of carbomer, 0.5-1 part of N, N-dicarboxymethyl alanine trisodium salt, 0.2-0.1 part of carboxymethyl cellulose and 50-250ppm stable chlorine dioxide powder. The preparation method of the gynecological antibacterial gel comprises the five steps of chlorine dioxide chelating solution preparation, gel matrix preparation, gel forming, pH value adjustment and finished product packaging, all the steps are accurately controlled, and the product quality is ensured. The invention provides a gynecological gel product which is high in initial flowability, can be quickly gelated in vivo and has a quick long-acting antibacterial function, solves the problems of non-ideal antibacterial effect, inconvenience in use, insufficient safety and the like of an existing gynecological nursing product, ensures the safety and stability of the product, overcomes many defects of a traditional product, and has a good application prospect. And a better choice is provided for female reproductive health care.

The invention discloses an aprepitant nano suspension pharmaceutical composition and a preparation method thereof. The aprepitant nano suspension pharmaceutical composition comprises aprepitant, a space stabilizer, an electrostatic stabilizer and water, the steric stabilizer is selected from one or more of poloxamer F188, poloxamer F407 and polyvinylpyrrolidone K30, and the steric stabilizer is selected from one or more of poloxamer F188, poloxamer F407 and polyvinylpyrrolidone K30; the electrostatic stabilizer is lauryl sodium sulfate or PCM. By selecting a specific stabilizer and a preparation method, subcutaneous injection of aprepitant is realized, the stability of the medicine is remarkably improved, and the medicine loading capacity is increased. In addition, according to the method, the preparation process is simplified, the formula screening time is shortened, and therefore the overall preparation time is shortened.

The invention provides an enzyme protective agent for a continuous glucose sensor and the continuous glucose sensor, the enzyme protective agent comprises the following components: poloxamer and a zwitterionic polymer, and the mass percent concentration of the poloxamer is 0.1%-2%, and the mass percent concentration of the zwitterionic polymer is 0.5%-5%. By adopting the technical scheme provided by the invention, the poloxamer and the zwitterionic polymer are introduced, so that an enzyme layer coating process can be optimized, a coffee ring effect can be inhibited, and the consistency and monitoring accuracy of the sensor can be improved; and on the premise of keeping the signal transmission performance of the sensor unchanged, the activity and long-term stability of the biological enzyme preparation in the production, storage, transportation and use processes are remarkably improved.

The invention provides a self-assembled temperature-sensitive hydrogel for neural restoration and a preparation method thereof. The hydrogel comprises the following raw materials: poloxamer, an acellular matrix and a neural factor in a mass concentration ratio of (5-10): (10-20): (1-4), preferably 5: 15: 1. The preparation method comprises the following steps: respectively preparing a poloxamer solution and an acellular matrix solution, mixing and heating the poloxamer solution and the acellular matrix solution to form a double-network three-dimensional gel structure, adding the nerve factors, stirring or ultrasonically dispersing, and heating to form the bioactive hydrogel. The hydrogel can rapidly form a stable three-dimensional structure at the body temperature, a support is provided for nerve repair, cell adhesion and proliferation are supported, and the added nerve factors are beneficial to maintaining the activity of neurons. Meanwhile, the hydrogel is in a liquid state at a low temperature, is convenient to inject, is fixed at a body temperature, is adjustable in degradation rate, is non-toxic, is suitable for local nerve injury treatment, and improves the bioavailability and safety of a nerve repair material.

Formulations for antibodies and / or antigen-binding molecules (ABMs) that bind to Porphyromonas gingivalis are described. The formulations may be used in treating infections involving P. gingivalis, such as periodontal disease. The formulations comprise at least one of histidine, saline, acetic acid, citrate phosphate, sucrose, and / or Poloxamer P188. In some embodiments, the formulations may also be pH adjusted.

The invention provides a formula of a temperature-sensitive recombinant human epidermal growth factor hydrogel composition, temperature-sensitive gel takes poloxamer as a drug carrier, and a terminal sterilization mode is filtration sterilization. The temperature-sensitive recombinant human epidermal growth factor hydrogel composition provided by the invention has unique advantages in the aspects of degerming process, temperature sensitivity, stability and practical applicability.

The invention provides a permeation promoting composition containing PDRN and glabridin and application of the permeation promoting composition in functional skin care products. The composition comprises the following components in percentage by mass: 0.01%-5% of glabridin, 0.1%-10% of glycyrrhizic acid ester stearate, 0.01%-2% of DNA sodium, 0.1%-10% of poloxamer, 0.05%-8% of carbomer, 0.5%-5% of sodium hyaluronate and the balance of one or more of water or solvents such as butanediol, glycerol, 1.3-propylene glycol and the like. In the composition, poloxamer is self-assembled in a system to form micelles, glabridin is wrapped in an inner core, and a PEO chain segment on an outer layer is combined with hyaluronic acid through a hydrogen bond to form a molecular-level wrapping structure, so that the problem of instability of glabridin is effectively solved, meanwhile, the problem of agglomeration of glabridin can be effectively avoided, and the whitening effect of glabridin is effectively promoted. Meanwhile, the glabridin, the glycyrrhizic acid ester stearate, the DNA sodium, the poloxamer, the carbomer and the hyaluronic acid are synergistically matched, so that the composition has good whitening, anti-wrinkle and penetration promoting effects.

The present invention provides an oregano essential oil inclusion complex with high encapsulation rate, high stability and anti-inflammatory and soothing effects, a preparation method and applications thereof. The composition of the oregano essential oil inclusion complex includes oregano essential oil, an encapsulating agent and an emulsifier. The emulsifier includes poloxamer, PPG-13-decyltetradeceth-24 and sodium bis(lauroylglutamyl)lysinate. The present invention does not use organic reagents such as absolute ethanol and ethyl acetate to participate in the encapsulation of oregano essential oil, which greatly ensures the safety of the oregano essential oil inclusion complex. Instead, it creatively uses common emulsifiers in cosmetics to participate in the essential oil encapsulation. The three emulsifiers cooperate with each other and have a synergistic effect in improving the encapsulation rate of oregano essential oil, enhancing the product stability and safety, so that the final encapsulation rate of oregano essential oil is as high as over 95%, and it has outstanding performance in terms of stability, safety, anti-inflammatory and soothing effects, water solubility and formulation compatibility.

Pharmaceutical composition comprising one or more cannabinoids (e.g., cannabidiol; 15-25 % w / w), one or more cyclodextrins or cyclodextrin derivatives (e.g., α-cyclodextrin (alpha-CD) or hydropropyl-β

The invention discloses an oral care composition and a method for improving the structural stability of the composition. The oral care composition comprises: 1) peroxide; 2) a fluoride ion source; 3) an antioxidant; 4) a thickening agent; 5) an orally acceptable carrier; wherein the antioxidant is prepared from one or two of butylated hydroxytoluene and butylated hydroxyanisole; and the thickening agent comprises poloxamer. Also disclosed are methods of improving the structural stability of an oral care composition comprising a peroxide and a fluoride ion source. When a fluoride ion source is added into the oral care composition containing peroxide, the composition is unstable in structure, and the paste is liquefied, while an antioxidant is further added into the formula of the oral care composition, and the antioxidant contains butylated hydroxytoluene or butylated hydroxyanisole, so that the oral care composition containing peroxide can be used for preparing the oral care composition containing peroxide. And when the thickening agent contains poloxamer, the condition that the paste structure of the composition is unstable can be improved.

The invention relates to the technical field of western-style clothes processing, in particular to an anti-wrinkle western-style clothes fabric and a processing technology thereof.The anti-wrinkle western-style clothes fabric is prepared by finishing base cloth through finishing liquid, the base cloth is wool blended fabric, and the wool blended fabric comprises wool, polyester fibers, lyocell fibers, spandex and conductive fibers; the finishing liquid is prepared from the following raw materials in parts by weight: 1 to 4 parts of polyoxyethylene sorbitan monooleate, 0.1 to 1 part of cocamidopropyl betaine, 2 to 6 parts of a fiber protecting agent, 80 to 120 parts of carboxyl-terminated hyperbranched polyester, 40 to 60 parts of butanetetracarboxylic acid, 30 to 50 parts of poloxamer, 0.1 to 2 parts of a silane coupling agent, 2 to 4 parts of an aziridine cross-linking agent and 900 to 1100 parts of water; the fabric has the advantage that the crease resistance of the business suit fabric is improved.

The invention belongs to the technical field of material sterilization, and particularly relates to application of poloxamer as an irradiation protective agent in sodium carboxymethyl cellulose hydrogel sterilization. Research finds that by adding poloxamer into sodium carboxymethyl cellulose, the poloxamer can be used as an irradiation protective agent to effectively protect sodium carboxymethyl cellulose hydrogel from being damaged by high-energy rays, so that the inherent structure and performance of the sodium carboxymethyl cellulose hydrogel are maintained, introduction of new impurities is avoided, the purity and safety of the sodium carboxymethyl cellulose hydrogel are maintained, the implementation process of protection measures is reduced, and the cost is reduced. Therefore, the method is more suitable for large-scale production, and has good practical application value.

The invention discloses periodontitis targeted sustained-release gel based on epithelial training immunization and a preparation method thereof, and relates to the technical field of biological medicine, and the preparation method comprises the following steps: modifying poloxamer, and dissolving the modified poloxamer in anhydrous acetonitrile; the preparation method comprises the following steps: dissolving RGD peptide in a PBS (Phosphate Buffer Solution), adding N-hydroxysuccinimide and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, and activating to obtain an activated RGD peptide solution; adding the activated RGD peptide solution into the modified poloxamer solution, and reacting at room temperature to obtain RGD peptide modified poloxamer; the RGD peptide modified poloxamer solution is mixed with a beta-glucan solution and a TLR2 agonist solution, and the periodontitis targeted slow-release gel is obtained. The gel provided by the invention specifically targets gingival epithelial cells, reduces inflammatory response and promotes periodontal tissue regeneration, has good biocompatibility and slow release performance, and can effectively control periodontitis and prevent relapse.

The invention relates to the technical field of biology, and particularly discloses an Ab-Taq enzyme freeze-drying protective agent and a preparation method and application thereof.The freeze-drying protective agent is prepared from, by mass, 2%-10% (w / v) of trehalose, 1%-3% (w / v) of polyethylene glycol 20000, 5%-15% (w / v) of mannitol, 0.1%-1% (w / v) of poloxamer 188 and sterilized purified water serving as a solvent. The freeze-drying protective agent disclosed by the invention not only can play a role in protecting and forming the Ab-Taq in a freeze-drying process, but also is simple in added protective agent component, and does not influence the amplification reaction of the Ab-Taq. The freeze-dried product prepared by using the optimized freeze-drying process is smooth in appearance molding and low in hygroscopicity, has no obvious change in amplification performance before and after freeze-drying, supports normal-temperature storage and transportation, does not need cold chain protection, and can avoid adverse effects on reagent performance caused by repeated freezing and thawing of conventional reagents.

The present invention discloses a nano-thermosensitive assembled gel for nasal administration, a preparation method thereof and its use, namely, mitochondrion-targeted puerarin nanoparticles, a thermosensitive gel, a preparation method thereof and its use. The nano-thermosensitive assembled gel for nasal administration of the present invention uses chitosan modified with SS-31 peptide having mitochondrion-targeting and transmembrane properties as a carrier material, and uses a thioketal cross-linking agent sensitive to reactive oxygen species (ROS) to cross-link the modified chitosan to prepare nanoparticles loaded with puerarin. Through a poloxamer thermosensitive gel system, a thermosensitive nanogel drug reservoir encapsulating the nanoparticles is constructed, and its application in the preparation of drugs for treating nervous system diseases realizes the targeting of the drug to the mitochondria of cerebral ischemic stroke injury, responsive cleavage in an environment rich in ROS, release of the drug, increase of the drug concentration in the mitochondria, and improvement of the brain bioavailability of puerarin, providing a more suitable and effective new dosage form for the treatment of stroke.

The invention belongs to the technical field of coal washing flotation reagents, and discloses a synthesis process of an environment-friendly coal washing flotation reagent foaming agent, and the synthesis process comprises the following steps: composite reaction; water phase fusion; according to the method, biodegradable alcohols such as pentanol and sec-octanol are adopted as main raw materials, and poloxamer and glycerol are matched, so that the problem of toxic residue of a traditional hydrocarbon foaming agent is avoided. In the synthesis process, low-boiling-point impurities are removed through molecular sieve filtration and a rotary evaporator, it is ensured that the purity of the raw materials is larger than or equal to 99.5%, the proportion of the final product deionized water reaches 40-50%, the use amount of an organic solvent is greatly reduced, nanoscale wrapping of alcohol molecules by an emulsifier OP-10 is achieved through a gradient water adding method and an ultrasonic-assisted emulsification technology, and the content of the alcohol molecules is reduced. And a microemulsion structure with high interfacial film strength is formed. After lauryl sodium sulfate is added as an auxiliary emulsifier, the strength of an oil-water interfacial film is improved by 30% or above, and the half-life period of foam is prolonged to 1.8 times of that of a traditional process.

The invention provides a method for detecting the content of poloxamer 188. Specifically, a high performance liquid chromatography method is adopted, octadecylsilane chemically bonded silica is used as a filler, a formic acid aqueous solution is used as a mobile phase A, a mixed solution of formic acid and isopropanol or a mixed solution of acetic acid and isopropanol is used as a mobile phase B, and isocratic or gradient elution is carried out; and an evaporative light scattering detector is adopted for detection. The detection method is high in sensitivity, and the content of the poloxamer 188 can be rapidly and accurately detected with high sensitivity, so that the quality controllability of the product is ensured.

The invention belongs to the technical field of medicines, particularly relates to the field of immunology, and more particularly relates to an adjuvant composition for vaccines as well as a preparation method and application of the adjuvant composition. The adjuvant is prepared from squalene, Tween 80, poloxamer 188 and oligonucleotide CpG1018. Experiments show that the adjuvant disclosed by the invention is obviously superior to an adjuvant in the prior art, so that the adjuvant has an application prospect.

Aqueous cleaning compositions and methods for making and using the same are disclosed herein. The aqueous cleaning compositions may comprise a surfactant system comprising a plurality of surfactants dispersed in an aqueous base, the plurality of surfactants comprising at least one anionic surfactant and at least one nonionic surfactant; and a plurality of viscosity modifying agents comprising ethanol, a poloxamer, or a combination thereof. The aqueous cleaning composition may have a viscosity of from about 500 cP to about 1500 cP.

The present invention relates to a hydrogel-based drug delivery system that can efficiently deliver the required amount of a drug to a desired location for a longer period of time. The hydrogel-based drug delivery system includes: an amphipathic block copolymer including a mixture of a first poloxamer and a second poloxamer that have different molecular weights; and a protein extract (containing elastin and collagen. A drug delivery composition for promoting tissue regeneration, according to the present invention, is mixed with a drug and introduced into the body, thus increasing the excretion time of the drug in the body, has phase transition properties of a liquid (sol) state at room temperature while being gelled at body temperature, thus being convenient to inject as an injectable agent, can be applied to various body parts.

The invention relates to the technical field of medical biopolymer materials, in particular to a two-component gynecological gel spray and a using method thereof.The two-component gynecological gel spray comprises a first component and a second component, and the first component at least comprises formylated multi-arm polyethylene glycol, formylated poloxamer and a solvent; the second component at least comprises a multi-amino polymer solution, the bi-component solution forms a film in the vagina and is cured in situ, and the vaginal gel has the characteristics of strong adhesion and strong corrosion resistance, can act on the vagina for a long time to realize long-acting treatment, and is more convenient to use and better in effect.

The invention relates to a pharmaceutical composition, which is prepared from adapalene, benzoyl peroxide, a traditional Chinese medicine extract, an acrylamide and acryloyl dimethyl sodium taurate copolymer, a mixture of isohexadecane and polysorbate 80, docusate sodium, EDTA (Ethylene Diamine Tetraacetic Acid) disodium, glycerol, poloxamer 124, propylene glycol and water, the traditional Chinese medicine extract comprises moutan bark, salvia miltiorrhiza, radix rehmanniae recen, radix sophorae flavescentis, coptis chinensis, rheum officinale, scutellaria baicalensis, menthol and borneol. According to the pharmaceutical composition disclosed by the invention, the synergistic antibacterial and anti-keratosis curative effects of adapalene and benzoyl peroxide can be maintained, and meanwhile, the occurrence rate of local skin dryness, erythema, desquamation, burning heat sensation and contact dermatitis can be remarkably reduced.

The application discloses a kind of by polydopamine mesoporous nanoparticles crosslinked sulfhydrylated hyaluronic acid hydrogel and its preparation method and application, with dopamine and 4-formylphenylboronic acid as monomer, with trimethylbenzene as and poloxamer as template agent, in weak alkaline (pH=8.4), oxygen exists in the environment, by the oxidation self-polymerization reaction between monomer Preparation of polydopamine nanoparticles with mesoporous structure.Then the water dispersion of polydopamine nanoparticles is mixed with sulfhydrylated hyaluronic acid solution according to certain proportion, and the hydrogel dressing with injectable property is prepared.The hydrogel is expected to be used as skin wound dressing for the treatment of diabetic wounds.